Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 9
Drug resistance rates of Klebsiella pneumoniae from 2017 to 2019.
| | 2017 | 2018 | 2019 | Drugs | Drug resistance rate (%) | Drugs | Drug resistance rate (%) | Drugs | Drug resistance rate (%) |
| Klebsiella pneumoniae | Trimethoprim | 100 | Ampicillin-sulbactam | 71.7 | Ampicillin-sulbactam | 66.7 | | Cefuroxime | 100 | Nitrofurantoin | 34.8 | Nitrofurantoin | 33.9 | | Piperacillin | 100 | Fosfomycin | 34.1 | Cotrimoxazole | 29.6 | | Piperacillin-sulbactam | 100 | Ceftriaxone | 30 | Aztreonam | 26.7 | | Ampicillin | 96.3 | Cotrimoxazole | 27 | Cotrimoxazole | 23.8 | | Cefazolin | 81.7 | Levofloxacin | 25.6 | Ciprofloxacin | 22.2 | | Nitrofurantoin | 78.8 | Aztreonam | 25.2 | Ceftazidime | 20.9 | | Fosfomycin | 72.5 | Ciprofloxacin | 25.1 | Levofloxacin | 19.9 | | Ampicillin-sulbactam | 70.8 | Ceftazidime | 23.9 | Gentamicin | 18.9 | | Ceftriaxone | 65.7 | Gentamicin | 22.7 | Cefepime | 17.1 | | Cefepime | 53.5 | Cefepime | 22.2 | Tobramycin | 13.5 | | Tobramycin | 52.6 | Tobramycin | 19 | Imipenem | 11.8 | | Aztreonam | 51.3 | Cefoperazone-sulbactam | 18.9 | Piperacillin-tazobactam | 11.3 | | Compound sulfadiazine | 50.8 | Imipenem | 17.8 | Cefoperazone-sulbactam | 11.1 | | Ceftazidime | 50 | Ertapenem | 17.3 | Ertapenem | 8.8 | | Cefotaxime | 50 | Piperacillin-tazobactam | 17 | Amikacin | 6.0 | | Ciprofloxacin | 49.2 | Amikacin | 12.2 | Tigecycline | 0.0 | | Cefoperazone | 48.6 | | | | | | Levofloxacin | 47.2 | | | | | | Gentamicin | 46.1 | | | | | | Piperacillin-tazobactam | 44.3 | | | | | | Imipenem | 40.2 | | | | | | Cefoperazone-sulbactam | 32.4 | | | | |
|
|